WMSA
RARX

Weiss Multi-Strategy Advisers’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-119,259
Closed -$5.6M – 707
2019
Q4 		$5.6M Buy
+119,259
New +$5.27M 0.09% 292

Other funds holding RARX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Weiss Multi-Strategy Advisers's RARX Position: Q1 2020 in Review

Weiss Multi-Strategy Advisers sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q1 2020, closing a stake of 119,259 shares — an estimated $5.6M sold.

Weiss Multi-Strategy Advisers first reported a position in RARX in Q4 2019 and held it in 1 quarter. The position peaked at $5.6M in Q4 2019. 144 funds tracked by Wall St. Rank hold RARX as of Q1 2020.

  • Weiss Multi-Strategy Advisers reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 119,259 Ra Pharmaceuticals, Inc. Common Stock shares in Q1 2020, an estimated $5.6M.
  • Weiss Multi-Strategy Advisers first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Ra Pharmaceuticals, Inc. Common Stock position peaked at $5.6M in Q4 2019.
  • 144 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q1 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2020, filed 15 May 2020.